MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Rare variant analysis of the PPMI dataset to uncover the complex genetic architecture of Parkinson’s disease

    d. BOBBILI, P. MAY, R. KRUEGER (Esch-sur-Alzette, Luxembourg)

    Objective: To unravel the genetic factors that play a role in PD we used the whole exome sequencing data available as a part of Parkinson…
  • 2017 International Congress

    First Reported Case of Parkinsonism in a Patient with Argininosuccinate Lyase Deficiency

    K. Woodward, D. Bhatti, E. Rush (Omaha, NE, USA)

    Objective: The purpose of this case report is to detail the phenotype of parkinsonism encountered in a patient with Argininosuccinate Lyase Deficiency (ASLD) that has…
  • 2017 International Congress

    Young Onset Parkinson’s Disease (YOPD): A different disease entity?

    H. Chan, Y. Cheung, D. Chau, V. Lo, C. Woo, S. Tse, T. Fung, A. Leung, W. Fong (Hong Kong, Hong Kong)

    Objective: To study the clinical manifestations of YOPD and Late Onset Parkinson’s Disease (LOPD) patients Background: Parkinson’s disease (PD) is a neurodegenerative disease commonly affecting…
  • 2017 International Congress

    Comorbid Normal Pressure Hydrocephalus with Parkinson’s disease: a call for clinical awareness

    A. Cucca, M. Biagioni, J. Golomb, J. Fleisher (New York, NY, USA)

    Objective: To examine a case of comorbid normal pressure hydrocephalus (NPH) with Parkinson’s Disease (PD). Background: PD and NPH are the most common high level…
  • 2017 International Congress

    Falls in Parkinson’s disease are related to delayed recovery time after unexpected external perturbations

    V. Beretta, F. Barbieri, D. Orcioli-Silva, P. Santos, M. Pereira, R. Vitório, L. Gobbi (Rio Claro, Brazil)

    Objective: The aim of this study was to analyze the postural adjustments in fallers and non-fallers Parkinson’s disease (PD) patients. Background: Adequate reactive postural response…
  • 2017 International Congress

    Effects of a Parkinson-Specific, Interdisciplinary Approach, To Inpatient Rehabilitation

    C. Benedict, D. Fredericks, C. Manganiello, H. Herrstrom, D. Schmitt, K. Lyons (Topeka, KS, USA)

    Objective: To demonstrate the effects of an interdisciplinary team approach in the evaluation and treatment of Parkinson’s disease (PD) patients, during inpatient rehabilitation. Background:  PD…
  • 2017 International Congress

    Preventing Levodopa Induced Dyskinesia with Docosohexanoid Acid in Parkinson Disease

    K. Chung, B. Lobb (Portland, OR, USA)

    Objective: The purpose of this study was to determine if Docosohexanoic acid (DHA) affects the speed and severity of development of levodopa induced dyskinesia (LID) in subjects starting levodopa (LD).…
  • 2017 International Congress

    A prospective comparison of apomorphine, STN deep brain stimulation and levodopa-carbidopa intestinal gel therapy for motor fluctuations in PD

    H.-L. Chiang, F. Chang, D. Tsui, Y. Tai, A. Ha, N. Mahant, J. Griffith, D. Galea, S. Kim, B. Cruse, H. Morales-Briceño (New Taipei City, Taiwan)

    Objective: To compare the clinical, functional and quality of life (QoL) outcomes in patients with advanced Parkinson’s disease (PD) following treatment with apomorphine (APO), either…
  • 2017 International Congress

    Postural Instability is a Predictor for Driving Cessation Among Parkinson’s Disease Drivers: A Study of a Computer-Based 3D Driving Simulator.

    O. Jitkritsadakul, S. Krootjohn, C. Thanawattano, C. Anan, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To develop tests to predict the driving capability of PD patients. Background: Continuing driving competence is a concern for Parkinson’s disease (PD) patients and…
  • 2017 International Congress

    [18F]-AV-1451 binding to neuromelanin in the substantia nigra in PD and PSP

    S. Coakeley, S.S. Cho, Y. Koshimori, P. Rusjan, A. Lang, S. Houle, A. Strafella (Toronto, ON, Canada)

    Objective: This study was designed to investigate the binding of [18F]-AV-1451 to neuromelanin in parkinsonisms. Uptake in the substantia nigra of Parkinson’s disease (PD) and…
  • « Previous Page
  • 1
  • …
  • 292
  • 293
  • 294
  • 295
  • 296
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley